Developer docs
API playgroundTry for free, no card

Search company profiles

Medix Infusion

Full company profile

uuid00029fw

Namestring
Medix Infusion
Legal namestring
Medix Infusion Services
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Medix Infusion is a privately held, technology-enabled healthcare platform founded in 2020 and headquartered in Addison, Texas, that delivers specialty infusion and injectable therapies to chronically ill and high-acuity patients. The company serves patients with conditions including multiple sclerosis, rheumatoid arthritis, Crohn's disease, ulcerative colitis, lupus, plaque psoriasis, myasthenia gravis, CIDP, and chronic asthma, using a formulary of 40+ medications such as Actemra, Benlysta, Ocrevus, Remicade, Entyvio, and IVIG. Its core customers are individual patients acquired primarily through B2B2C referrals from physicians, nurse practitioners, and hospitals, with additional direct-to-consumer inbound via website, phone, and email.

The platform operates through a hybrid care delivery model combining Ambulatory Infusion Suites—comfortable outpatient settings with recliners, iPads, Wi-Fi, and refreshments staffed by nurse practitioners and RNs—and a state-of-the-art Home Infusion Pharmacy with advanced cleanrooms that compound medications for home delivery or first-dose-and-teach clinic visits. The underlying technology stack is described as an integrated, workflow-driven patient intake system that handles insurance authorization, dual medical/pharmacy benefit verification, scheduling, and patient communications across all departments. Digital patient tools (app and website) support condition management, virtual visits, and clinical team communication. The company holds ACHC accreditation and operates 55+ clinic locations across 7 states (Texas, Arizona, Oregon, Kansas, Washington, Utah, Missouri).

Medix generates revenue by administering and dispensing specialty infusion therapies billed through patient insurance—leveraging both medical and pharmacy benefits—with patient out-of-pocket estimates provided upfront and financial assistance programs available. GTM is executed via a hybrid field-sales and direct-to-consumer motion: enterprise sales teams cultivate physician and hospital referral networks, while marketing channels (website, phone, email, provider referrals, patient testimonials) drive top-of-funnel patient acquisition. The company is backed by $35 million in Series B funding raised in January 2023 from Echo Health Ventures, Pittco Direct Investments II, and Noro-Moseley Partners, and is led as of April 2026 by President and CEO Carmine DeNardo, who previously scaled ReCept Pharmacy from $32M to over $600M in revenue.

Short descriptiontext

Medix Infusion is a private, technology-enabled specialty infusion platform operating 55+ ambulatory infusion suites and a home infusion pharmacy across 7 states, delivering biologic and injectable therapies to chronically ill patients in underserved markets via physician referrals and dual medical/pharmacy benefit billing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAddison, United States
HQ citystring
Addison
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices58 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ambulatory infusion services, home infusion pharmacy, specialty infusion therapy, infusion clinic network, chronic disease infusion care
Industry3 codes
PRIMARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFABAF
Infusion Therapy Centers (Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFAEAE
Home Infusion Therapy Providers
NAICS code3 codes
  • Home Health Care Services621610
  • All Other Outpatient Care Centers621498
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Home Health Care Services8082
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Specialty Infusion Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Infusion and Injectable Therapy Services
TypeManaged Services
Description

Medix Infusion provides medical infusion and injectable therapies through both major medical insurance and pharmacy coverage benefits. Services are administered at ambulatory infusion suites or delivered through the home infusion pharmacy.

medixinfusion.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Insurance-based pricing with financial assistance options
ModelOtherBilling cadencePay-as-you-go
Notes

Services are billed through insurance (medical and pharmacy benefits). The team verifies benefits and handles prior authorizations. Financial assistance programs are available for patients.

medixinfusion.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Medix Infusion delivers specialty infusion and injectable therapies through a hybrid model of Ambulatory Infusion Suites and a Home Infusion Pharmacy. Services span a formulary of 40+ medications including anti-infectives, biologics, IVIG, Actemra, Benlysta, Ocrevus, Remicade, and Entyvio, supported by technology-enabled intake workflows that handle insurance authorization, benefit verification, scheduling, and patient communications across 55+ clinic locations in seven U.S. states.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Patients contacted within 2-3 business days after referral order
+2 more records
Product overview1 text field

Medix Infusion is a healthcare platform providing infusion and injectable therapies through a hybrid model combining Ambulatory Infusion Suites and Home Infusion Pharmacy services. The platform offers anti-infectives, biologics, IVIG, and other injectable treatments across a formulary of 40+ medications including Actemra, Benlysta, Ocrevus, Remicade, Entyvio, and others. The company operates 55+ clinic locations across Texas, Arizona, Oregon, Kansas, Washington, Utah, and Missouri, supported by technology-enabled intake workflows and digital patient tools.

Product and service4 records
1Ambulatory Infusion Suites
CategorySpecialty Infusion Services
Description

Outpatient infusion centers providing a comfortable setting with recliners, tablets, Wi-Fi, and refreshments where patients receive infusion therapies (anti-infectives, biologics, IVIG, and other injectable treatments) administered by nurse practitioners, RNs, and clinical support staff. For patients with chronic and high-acuity conditions who need clinic-based infusion therapy.

2Home Infusion Pharmacy
CategorySpecialty Pharmacy
Description

State-of-the-art home infusion pharmacy with advanced clean-rooms for the accurate and safe preparation and prompt secure delivery of medication therapy to patient homes or nearby clinics, including coordination of first dose-and-teach visits. For patients requiring home-based infusion therapy or transitioning from clinic to home settings.

3Digital Patient Tools
CategoryPatient Engagement Technology
Description

App and website platform enabling patients to manage their condition, schedule virtual visits with care teams, access educational video content, and communicate with clinical support staff. For Medix Infusion patients and their care teams.

4Clinical Support Services
CategoryCare Coordination Services
Description

Hands-on support from pharmacists, patient care coordinators, and clinical experts providing intake workflow including insurance authorization, benefit verification, scheduling, and patient communication. For referring providers and patients using Medix Infusion services.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Medix Infusion partners with pharmaceutical manufacturers to guide and monitor patients through all stages of clinical trials.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Coordinates with home health agencies when necessary for patient care, particularly for home infusion services.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty infusion services provider offering both home infusion and ambulatory infusion suites. Competes directly with Medix across chronic specialty biologics and complex therapy administration.

TypeDirect peer
Description

Provider of home infusion, specialty pharmacy, and respiratory therapy services. Directly comparable home infusion and specialty drug delivery operating model.

TypeDirect peer
Description

Franchise-based ambulatory/home infusion network operating across multiple U.S. states. Comparable hybrid model and specialty therapy focus to Medix.

TypeBroad incumbent
Description

CVS Health-owned national home and specialty infusion provider. Operates a broader pharmacy and retail-health portfolio but directly overlaps Medix in home infusion and specialty injectable therapies.

TypeDirect peer
Description

Largest independent provider of home and alternate-site infusion services in the U.S. with national coverage across all 50 states. Directly comparable to Medix across both home infusion pharmacy and ambulatory infusion suite service lines.

TypeDirect peer
Description

Privately held specialty infusion pharmacy focused on chronic disease biologics. Closely comparable specialty formulary (MS, RA, IBD, immunology) and home infusion model.

TypeBroad incumbent
Description

UnitedHealth Group's specialty/home infusion arm with national scale. Directly competes in home infusion and specialty pharmacy infusion services, with the advantage of captive payer relationships.

TypeBroad incumbent
Description

Specialty pharmacy arm of Centene serving complex chronic conditions with home and ambulatory infusion capabilities. Overlaps Medix in specialty biologic infusion for Medicaid and complex patient populations.

TypeDirect peer
Description

Specialty home infusion pharmacy focused on immune globulin (IVIG/SCIG) and related chronic therapies. Comparable specialty pharmacy infusion services and clinical patient management.

TypeDirect peer
Description

Operates ambulatory infusion centers and home infusion services with a national footprint. Overlaps Medix in clinic-based and home infusion for chronic and specialty conditions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medix Infusion

Specialty Infusion Servicesmedixinfusion.com

Medix Infusion is a private, technology-enabled specialty infusion platform operating 55+ ambulatory infusion suites and a home infusion pharmacy across 7 states, delivering biologic and injectable therapies to chronically ill patients in underserved markets via physician referrals and dual medical/pharmacy benefit billing.

What Medix Infusion does

Medix Infusion is a privately held, technology-enabled healthcare platform founded in 2020 and headquartered in Addison, Texas, that delivers specialty infusion and injectable therapies to chronically ill and high-acuity patients. The company serves patients with conditions including multiple sclerosis, rheumatoid arthritis, Crohn's disease, ulcerative colitis, lupus, plaque psoriasis, myasthenia gravis, CIDP, and chronic asthma, using a formulary of 40+ medications such as Actemra, Benlysta, Ocrevus, Remicade, Entyvio, and IVIG. Its core customers are individual patients acquired primarily through B2B2C referrals from physicians, nurse practitioners, and hospitals, with additional direct-to-consumer inbound via website, phone, and email.

The platform operates through a hybrid care delivery model combining Ambulatory Infusion Suites—comfortable outpatient settings with recliners, iPads, Wi-Fi, and refreshments staffed by nurse practitioners and RNs—and a state-of-the-art Home Infusion Pharmacy with advanced cleanrooms that compound medications for home delivery or first-dose-and-teach clinic visits. The underlying technology stack is described as an integrated, workflow-driven patient intake system that handles insurance authorization, dual medical/pharmacy benefit verification, scheduling, and patient communications across all departments. Digital patient tools (app and website) support condition management, virtual visits, and clinical team communication. The company holds ACHC accreditation and operates 55+ clinic locations across 7 states (Texas, Arizona, Oregon, Kansas, Washington, Utah, Missouri).

Medix generates revenue by administering and dispensing specialty infusion therapies billed through patient insurance—leveraging both medical and pharmacy benefits—with patient out-of-pocket estimates provided upfront and financial assistance programs available. GTM is executed via a hybrid field-sales and direct-to-consumer motion: enterprise sales teams cultivate physician and hospital referral networks, while marketing channels (website, phone, email, provider referrals, patient testimonials) drive top-of-funnel patient acquisition. The company is backed by $35 million in Series B funding raised in January 2023 from Echo Health Ventures, Pittco Direct Investments II, and Noro-Moseley Partners, and is led as of April 2026 by President and CEO Carmine DeNardo, who previously scaled ReCept Pharmacy from $32M to over $600M in revenue.

Medix Infusion firmographics

Firmographics
Name
Medix Infusion
Legal name
Medix Infusion Services
Website
https://medixinfusion.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
101–250 employees
Short description
Medix Infusion is a private, technology-enabled specialty infusion platform operating 55+ ambulatory infusion suites and a home infusion pharmacy across 7 states, delivering biologic and injectable therapies to chronically ill patients in underserved markets via physician referrals and dual medical/pharmacy benefit billing.
Ownership category
akta.pro rank

Medix Infusion industry classification

Industry
Product category
Specialty Infusion Services
NAICS
Home Health Care Services (621610), All Other Outpatient Care Centers (621498), Ambulatory Health Care Services (621)
SIC
Services-Home Health Care Services (8082), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFABAF
Infusion Therapy Centers (Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFAEAE
Home Infusion Therapy Providers

Keywords

  • Ambulatory infusion services
  • Home infusion pharmacy
  • Specialty infusion therapy
  • Infusion clinic network
  • Chronic disease infusion care

Where Medix Infusion is headquartered

Location

Headquarters

HQ city
Addison
HQ country
United States
HQ region
North America

Offices58 records

Markets served

Medix Infusion business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Infusion and Injectable Therapy Services: Medix Infusion provides medical infusion and injectable therapies through both major medical insurance and pharmacy coverage benefits. Services are administered at ambulatory infusion suites or delivered through the home infusion pharmacy.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goInsurance-based pricing with financial assistance options

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Medix Infusion product offering

Product offering

Core offering

Medix Infusion delivers specialty infusion and injectable therapies through a hybrid model of Ambulatory Infusion Suites and a Home Infusion Pharmacy. Services span a formulary of 40+ medications including anti-infectives, biologics, IVIG, Actemra, Benlysta, Ocrevus, Remicade, and Entyvio, supported by technology-enabled intake workflows that handle insurance authorization, benefit verification, scheduling, and patient communications across 55+ clinic locations in seven U.S. states.

Product overview

Medix Infusion is a healthcare platform providing infusion and injectable therapies through a hybrid model combining Ambulatory Infusion Suites and Home Infusion Pharmacy services. The platform offers anti-infectives, biologics, IVIG, and other injectable treatments across a formulary of 40+ medications including Actemra, Benlysta, Ocrevus, Remicade, Entyvio, and others. The company operates 55+ clinic locations across Texas, Arizona, Oregon, Kansas, Washington, Utah, and Missouri, supported by technology-enabled intake workflows and digital patient tools.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ambulatory Infusion Suites Outpatient infusion centers providing a comfortable setting with recliners, tablets, Wi-Fi, and refreshments where patients receive infusion therapies (anti-infectives, biologics, IVIG, and other injectable treatments) administered by nurse practitioners, RNs, and clinical support staff. For patients with chronic and high-acuity conditions who need clinic-based infusion therapy.
  • Home Infusion Pharmacy State-of-the-art home infusion pharmacy with advanced clean-rooms for the accurate and safe preparation and prompt secure delivery of medication therapy to patient homes or nearby clinics, including coordination of first dose-and-teach visits. For patients requiring home-based infusion therapy or transitioning from clinic to home settings.
  • Digital Patient Tools App and website platform enabling patients to manage their condition, schedule virtual visits with care teams, access educational video content, and communicate with clinical support staff. For Medix Infusion patients and their care teams.
  • Clinical Support Services Hands-on support from pharmacists, patient care coordinators, and clinical experts providing intake workflow including insurance authorization, benefit verification, scheduling, and patient communication. For referring providers and patients using Medix Infusion services.

Quantifiable outcome

  • Patients contacted within 2-3 business days after referral order
  • +2 more outcomes

Companies that use Medix Infusion

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Medix Infusion technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Medix Infusion partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered supporting.

  • Pharmaceutical ManufacturerssupportingStrategic or Co-development PartnerMedix Infusion partners with pharmaceutical manufacturers to guide and monitor patients through all stages of clinical trials.
  • Home Health AgenciessupportingChannel Partner/ Reseller/ DistributorCoordinates with home health agencies when necessary for patient care, particularly for home infusion services.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

Medix Infusion competitors and assessment

Company assessment

Direct peers

  • Soleo Health: Specialty infusion services provider offering both home infusion and ambulatory infusion suites. Competes directly with Medix across chronic specialty biologics and complex therapy administration.
  • PromptCare: Provider of home infusion, specialty pharmacy, and respiratory therapy services. Directly comparable home infusion and specialty drug delivery operating model.
  • Vital Care Infusion Services: Franchise-based ambulatory/home infusion network operating across multiple U.S. states. Comparable hybrid model and specialty therapy focus to Medix.
  • Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S. with national coverage across all 50 states. Directly comparable to Medix across both home infusion pharmacy and ambulatory infusion suite service lines.
  • BioMatrix Specialty Pharmacy: Privately held specialty infusion pharmacy focused on chronic disease biologics. Closely comparable specialty formulary (MS, RA, IBD, immunology) and home infusion model.
  • Nufactor: Specialty home infusion pharmacy focused on immune globulin (IVIG/SCIG) and related chronic therapies. Comparable specialty pharmacy infusion services and clinical patient management.
  • InfuSystem: Operates ambulatory infusion centers and home infusion services with a national footprint. Overlaps Medix in clinic-based and home infusion for chronic and specialty conditions.

Broad incumbents

  • Coram CVS Health Infusion Services: CVS Health-owned national home and specialty infusion provider. Operates a broader pharmacy and retail-health portfolio but directly overlaps Medix in home infusion and specialty injectable therapies.
  • Optum Infusion (formerly Amerita and BriovaRx): UnitedHealth Group's specialty/home infusion arm with national scale. Directly competes in home infusion and specialty pharmacy infusion services, with the advantage of captive payer relationships.
  • AcariaHealth (Centene): Specialty pharmacy arm of Centene serving complex chronic conditions with home and ambulatory infusion capabilities. Overlaps Medix in specialty biologic infusion for Medicaid and complex patient populations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Medix Infusion social profiles

Digital presence

Medix Infusion compliance and trust

Trust signal

Compliance1 record

Medix Infusion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medix Infusion leadership team

Management profile

Number of profiles

Profiles12 records

Medix Infusion funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medix Infusion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medix Infusion

What does Medix Infusion do?

Medix Infusion delivers specialty infusion and injectable therapies through a hybrid model of Ambulatory Infusion Suites and a Home Infusion Pharmacy. Services span a formulary of 40+ medications including anti-infectives, biologics, IVIG, Actemra, Benlysta, Ocrevus, Remicade, and Entyvio, supported by technology-enabled intake workflows that handle insurance authorization, benefit verification, scheduling, and patient communications across 55+ clinic locations in seven U.S. states.

Is Medix Infusion a public or private company?

Medix Infusion is a private company. It is classified as venture growth investor backed and is currently operating.

When was Medix Infusion founded?

Medix Infusion was founded in 2020. It employs 101 to 250 people.

Where is Medix Infusion based?

Medix Infusion is headquartered in Addison, United States, in the North America region.

How does Medix Infusion make money?

One revenue line is on record: infusion and Injectable Therapy Services.

Who are Medix Infusion's main competitors?

Direct peers on record are Soleo Health, PromptCare, Vital Care Infusion Services, Option Care Health, BioMatrix Specialty Pharmacy, Nufactor and InfuSystem. Broad incumbents are Coram CVS Health Infusion Services, Optum Infusion (formerly Amerita and BriovaRx) and AcariaHealth (Centene).

Does Medix Infusion have an API?

No public API is recorded for Medix Infusion.

What industry is Medix Infusion in?

Medix Infusion's product category is Specialty Infusion Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFABAF, Infusion Therapy Centers (Outpatient). Its NAICS code is 621610 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrwebMedix Infusion Names Carmine DeNardo as President and CEOMedix Infusion announced the appointment of Carmine DeNardo as President and Chief Executive Officer, marking a pivotal step as the company accelerates its national expansion in specialty and ambulatory infusion services. DeNardo brings extensive experience in pharmacy services, having previously scaled ReCept Pharmacy from $32 million to over $600 million in revenue before its acquisition by Omnicell. The appointment signals the company's ambition to strengthen its position as a national leader in infusion pharmacy services while continuing its multi-state expansion across Texas, Arizona, Oregon, Kansas, Washington, Utah, and Missouri.The Dallas Morning NewsA new Dallas unicorn gets 2023′s venture funding cycle off to a fast startFive North Texas startups raised funding in 2023, led by ShiftKey's $300 million round that valued it at $2 billion. The region's venture funding rebounded after a 2022 slump, with deals including $40 million for Inbenta and $35 million for Medix Infusion.EchohealthventuresMedix Infusion secures $35 million in Series B led by Echo Health VenturesMedix Infusion closed a $35 million Series B funding round led by Echo Health Ventures, with participation from Pittco Direct Investments II and Noro-Moseley Partners. The company will utilize the capital to support organic growth and acquire the infusion operations of the Center for Neurology and Spine in Arizona. This expansion extends Medix's geographic footprint into its fifth state, joining existing operations in Texas, Oregon, Kansas, and Missouri.Business Wire BlogMedix Infusion Secures $35 Million in Series B Led by Echo Health VenturesMedix Infusion closed a $35 million Series B round led by Echo Health Ventures, with Pittco Direct Investments II and Noro-Moseley Partners participating. The company will use the funds to acquire the infusion operations of the Center for Neurology and Spine in Arizona, expanding into its fifth state.Business Wire BlogMedix Infusion Secures $35 Million in Series B Led by Echo Health VenturesMedix Infusion closed a $35 million Series B funding round led by Echo Health Ventures, with participation from Pittco Direct Investments II and Noro-Moseley Partners. The company will use the funds to acquire the infusion operations of the Center for Neurology and Spine in Arizona, expanding into its fifth state.Venture Capital Access OnlineMedix Infusion Secures $35 Million in Series B Led by Echo Health VenturesMedix Infusion closed a $35 million Series B funding round led by Echo Health Ventures, with participation from Pittco Direct Investments II and Noro-Moseley Partners. The company will utilize the capital to expand into Arizona through the acquisition of infusion operations from the Center for Neurology and Spine.Medical BuyerMedix Infusion secures $35M in Series B fundingMedix Infusion has closed a $35 million Series B funding round led by Echo Health Ventures, with participation from Pittco Direct Investments II and Noro-Moseley Partners. The company will use the capital for organic growth and to acquire infusion operations from the Center for Neurology and Spine in Arizona. This transaction expands Medix's geographic footprint into its fifth state, adding to existing operations in Texas, Oregon, Kansas, and Missouri.